|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.070 USD | +0.40% |
|
+1.20% | -12.13% |
Company Valuation: Unicycive Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30.84 | 8.148 | 30.16 | 82.44 | 124 | 138.9 | - | - |
| Change | - | -73.58% | 270.11% | 173.36% | 50.43% | 12% | - | - |
| Enterprise Value (EV) | 30.84 | 8.148 | 30.16 | 82.44 | 124 | 138.9 | 138.9 | 138.9 |
| Change | - | -73.58% | 270.11% | 173.36% | 50.43% | 12% | 0% | 0% |
| P/E | -2.4x | -0.45x | -0.68x | -1.42x | -3.46x | -3.58x | 0.99x | 0.53x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0x | -0.1x | 0x | 0x | 0.2x | -0x | 0x |
| Capitalization / Revenue | - | 8.57x | 44.7x | - | - | 36.5x | 0.48x | 0.25x |
| EV / Revenue | - | 0x | 0x | - | - | 36.5x | 0.48x | 0.25x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.49x | 0.67x | 0.36x |
| EV / FCF | -0x | - | -0x | -0x | -0x | -5.14x | -3.82x | 0.83x |
| FCF Yield | -18.8% | - | -60.7% | -34.8% | -25.3% | -19.4% | -26.2% | 120% |
| Dividend per Share 2 | - | - | - | - | - | - | 2.3 | 5.8 |
| Rate of return | - | - | - | - | - | - | 45.4% | 114% |
| EPS 2 | -8.6 | -12 | -12.8 | -5.6 | -1.67 | -1.415 | 5.146 | 9.648 |
| Distribution rate | - | - | - | - | - | - | 44.7% | 60.1% |
| Net sales 1 | - | 0.951 | 0.675 | - | - | 3.804 | 288.4 | 566.6 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -8.977 | -18.05 | -20.77 | -32.12 | -29.52 | -39.78 | 208.2 | 386.1 |
| Net income 1 | -10.02 | -18.06 | -31.41 | -37.82 | -26.56 | -40.34 | 186.2 | 366.7 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 20.600 | 5.400 | 8.677 | 7.942 | 5.770 | 5.070 | 5.070 | 5.070 |
| Nbr of stocks (in thousands) | 1,497 | 1,509 | 3,475 | 10,380 | 21,491 | 27,393 | - | - |
| Announcement Date | 3/31/22 A | 3/31/23 A | 3/28/24 A | 3/31/25 A | 3/30/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.58x | - | - | - | 139M | |
| 20.44x | 7.13x | 14.71x | 1.42% | 68.12B | |
| 31.44x | 8.03x | 24.45x | 0.05% | 55.18B | |
| -81.56x | 15.59x | -67.39x | -.--% | 28.63B | |
| 30.46x | 5.97x | 15.8x | -.--% | 23.99B | |
| -14.71x | 5.23x | -6.82x | -.--% | 23.53B | |
| 25.54x | 4.8x | 16.1x | -.--% | 18.45B | |
| -1250.29x | 38.99x | -15519.34x | -.--% | 16.44B | |
| 47.61x | 19.33x | 49.78x | 0.08% | 15.83B | |
| 16.76x | 4.95x | 11.57x | -.--% | 13.4B | |
| Average | -117.79x | 12.23x | -1,717.91x | 0.17% | 26.37B | |
| Weighted average by Cap. | -67.98x | 10.41x | -960.73x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- UNCY Stock
- Valuation Unicycive Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
